Thyrocare Technologies Ltd's Q1FY19 consolidated net profit rises 6.45% yoy to Rs23.44cr: In-line with Estimates

The company’s consolidated revenue stood at Rs97.15cr, up 10.7% yoy and 0.51% qoq.

Aug 12, 2018 04:08 IST India Infoline Research Team

Thyrocare Technologies Ltd Q1FY19

Consolidated Results Q1FY19: (Rs. in cr)

Q1FY19 YoY (%)
Revenue 97.15 10.7
EBITDA 41.20 13.1
EBITDA Margin (%) 42.4 90
Net Profit (adjusted) 23.44 6.5
***EBITDA margin change is bps

Thyrocare’s revenue in Q1FY19 grew by 10.7% yoy to Rs97.2cr. EBITDA rose 13.1% yoy to Rs41.2cr in Q1FY19 vs. Rs36.4cr in Q1FY18. EBITDA margins expanded 90bps yoy to 42.4% in Q1FY19 vs. 41.5% in Q1FY18. PAT increased 6.5% yoy to Rs23.4cr in Q1FY19 vs. Rs22cr inQ1FY18.
  • Revenue from the diagnostic business rose 9% yoy to Rs88.8cr in Q1FY19.
  • Imaging business revenue grew 41.6% yoy to Rs8cr in Q1FY19.
  • Thyrocare’s EBITDA margin was the highest this quarter, compared to the last four quarters.
  • At the EBIT level, the diagnostic segment saw 22bps yoy margin expansion, while the imaging business saw 985bps yoy margin expansion.
  • PAT was impacted by a 52.5% yoy decline in other income and higher tax rate in Q1FY19.





Technical View:

Thyrocare Technologies Ltd ended at Rs. 615, down by 10.3 points or 1.65% from its previous closing of Rs. 625.30 on the BSE.
The scrip opened at Rs. 619.25 and touched a high and low of Rs. 624.50 and Rs. 607.95 respectively. A total of 20,017 (NSE+BSE) shares were traded on the counter. The stock traded below its 200 DMA.

Related Story